Literature DB >> 12882914

Endothelial differentiation gene receptors in pancreatic islets and INS-1 cells.

Suzanne G Laychock1, Yingrao Tian, Shawn M Sessanna.   

Abstract

The endothelial differentiation gene (EDG) receptors are a class of G protein-coupled receptors. EDG-1, -3, -5, -6, and -8 bind the bioactive lipid sphingosine-1-phosphate (SPP) as the primary signaling ligand. EDG-2, -4, and -7 bind the ligand lysophosphatidic acid. EDG-1, -2, -3, -5, -6, and -7, but not -8, mRNAs were expressed in isolated rat pancreatic islets, whereas INS-1 insulinoma cells expressed only EDG-1, -2, -3, and -5 mRNAs. EDG-4 mRNA was expressed in mouse islets. EDG-1 mRNA but not EDG-3 mRNA was rapidly induced relative to 18S rRNA after stimulation of isolated islets with phorbol 12-myristate 13-acetate (PMA) or cholecystokinin-8S for 2 h. The protein kinase C inhibitor GF 109203X blocked the EDG-1 induction by PMA. Similarly, in islets stimulated for 2 h with 17 mmol/l glucose, the relative EDG-1 mRNA levels increased almost twofold compared with levels in control islets at 5.5 mmol/l glucose. In contrast, after 11 mmol/l glucose stimulation for 7 days, the relative levels of rat islet EDG-1 mRNA were significantly reduced to 54% below that of islets cultured at 5.5 mmol/l glucose. There was no change in relative EDG-3 mRNA levels. Stimulation of EDG receptors in islets and INS-1 cells with SPP inhibited glucagon-like peptide 1 (GLP-1)-stimulated cAMP production and insulin secretion in a concentration-dependent manner. Pertussis toxin antagonized the SPP effects on insulin release. Thus, EDG receptors are expressed in pancreatic islet beta-cells and G(i) seems to mediate the inhibition by SPP of adenylyl cyclase and cAMP formation and inhibition of the stimulation of insulin secretion by GLP-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12882914     DOI: 10.2337/diabetes.52.8.1986

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

1.  An engineered macroencapsulation membrane releasing FTY720 to precondition pancreatic islet transplantation.

Authors:  Daniel T Bowers; Claire E Olingy; Preeti Chhabra; Linda Langman; Parker H Merrill; Ritu S Linhart; Michael L Tanes; Dan Lin; Kenneth L Brayman; Edward A Botchwey
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2017-02-27       Impact factor: 3.368

2.  Sphingosine 1-phosphate (S1P) regulates glucose-stimulated insulin secretion in pancreatic beta cells.

Authors:  Jamie Cantrell Stanford; Andrew J Morris; Manjula Sunkara; Gabriel J Popa; Kara L Larson; Sabire Özcan
Journal:  J Biol Chem       Date:  2012-03-02       Impact factor: 5.157

3.  ATP-independent glucose stimulation of sphingosine kinase in rat pancreatic islets.

Authors:  L D Mastrandrea; S M Sessanna; A Del Toro; S G Laychock
Journal:  J Lipid Res       Date:  2010-04-05       Impact factor: 5.922

4.  Sphingosine kinase 1 knockdown reduces insulin synthesis and secretion in a rat insulinoma cell line.

Authors:  N M Hasan; M J Longacre; S W Stoker; M A Kendrick; N R Druckenbrod; S G Laychock; L D Mastrandrea; M J MacDonald
Journal:  Arch Biochem Biophys       Date:  2011-12-04       Impact factor: 4.013

Review 5.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

6.  Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic beta-cells.

Authors:  Toshiyuki Imasawa; Kentaro Koike; Isao Ishii; Jerold Chun; Yutaka Yatomi
Journal:  Biochem Biophys Res Commun       Date:  2010-01-12       Impact factor: 3.575

7.  Sphingosine-1-phosphate induces islet β-cell proliferation and decreases cell apoptosis in high-fat diet/streptozotocin diabetic mice.

Authors:  Yizhi He; Bingyin Shi; Xinrui Zhao; Jing Sui
Journal:  Exp Ther Med       Date:  2019-09-11       Impact factor: 2.447

8.  Inhibition of ceramide de novo synthesis with myriocin affects lipid metabolism in the liver of rats with streptozotocin-induced type 1 diabetes.

Authors:  Krzysztof Kurek; Patrycja Wiesiołek-Kurek; Dominika M Piotrowska; Bartłomiej Łukaszuk; Adrian Chabowski; Małgorzata Żendzianendzian-Piotrowska
Journal:  Biomed Res Int       Date:  2014-02-19       Impact factor: 3.411

Review 9.  Roles of Sphingolipid Metabolism in Pancreatic β Cell Dysfunction Induced by Lipotoxicity.

Authors:  Julien Véret; Lara Bellini; Paola Giussani; Carl Ng; Christophe Magnan; Hervé Le Stunff
Journal:  J Clin Med       Date:  2014-06-20       Impact factor: 4.241

Review 10.  On the dynamics of the human endocrine pancreas and potential consequences for the development of type 1 diabetes.

Authors:  Oskar Skog; Olle Korsgren
Journal:  Acta Diabetol       Date:  2019-09-13       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.